STOCK TITAN

[8-K] Bleichroeder Acquisition Corp. I Unit Reports Material Event

Filing Impact
(Moderate)
Filing Sentiment
(Neutral)
Form Type
8-K
Rhea-AI Filing Summary

VirnetX Holding Corp. (VHC) filed a Form 4 reporting an automatic, non-discretionary insider transaction by Chief Scientist Robert D. Short III on 07/07/2025. The company withheld 50 common shares (Transaction Code F) at a price of $12.34 to satisfy payroll and income-tax obligations linked to previously granted restricted stock awards. The explanatory note confirms the transaction is strictly for tax settlement and does not involve an open-market sale.

Post-transaction ownership stands at 31,848 direct shares and 11,278 indirect shares held through The Short Revocable Living Trust, leaving Short’s overall economic exposure essentially unchanged. No derivative securities were exercised, acquired, or disposed of, and no other insider activity was disclosed. Given the immaterial size (≈0.1 % of Short’s total holdings) and its administrative nature, the filing carries limited investment significance and signals no shift in insider sentiment toward VirnetX.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti premi azionari vincolati. La nota esplicativa conferma che la transazione è esclusivamente per il regolamento fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, lasciando sostanzialmente invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati, né sono state divulgate altre attività da parte degli insider. Considerata la dimensione irrilevante (≈0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional de un insider, el Chief Scientist Robert D. Short III, el 07/07/2025. La compañía retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones fiscales y de nómina vinculadas a premios de acciones restringidas otorgadas previamente. La nota explicativa confirma que la transacción es únicamente para el pago de impuestos y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se divulgó otra actividad de insiders. Dado el tamaño insignificante (≈0,1 % de las tenencias totales de Short) y su naturaleza administrativa, la presentación tiene poca relevancia para la inversión y no señala un cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 판매와는 관련이 없다고 확인합니다.

거래 후 직접 보유 주식은 31,848주, The Short Revocable Living Trust를 통한 간접 보유 주식은 11,278주로, Short의 전체 경제적 노출은 사실상 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 거래 규모가 미미(Short 총 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이 제출은 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자 심리 변화 신호가 아닙니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et salariales liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement le règlement fiscal et n’implique pas une vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions détenues via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Étant donné la taille négligeable (≈0,1 % du total des avoirs de Short) et son caractère administratif, ce dépôt a une signification limitée pour les investisseurs et ne signale aucun changement dans le sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien, die über The Short Revocable Living Trust gehalten werden, wodurch sich seine wirtschaftliche Gesamtposition im Wesentlichen nicht ändert. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und es wurden keine weiteren Insider-Aktivitäten offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung geringe investitionsbezogene Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

Positive
  • None.
Negative
  • None.

Insights

TL;DR: Only 50 shares withheld for taxes; negligible impact and neutral signal.

The Code F designation reveals an automatic share surrender to cover tax obligations on vested stock, a routine event that does not reflect a discretionary buy or sell decision. Post-withholding, the insider still controls roughly 43 k shares, indicating sustained alignment with shareholders. Because the transaction involves less than 1 % of his position and no derivatives, liquidity or valuation impact is essentially nil. From a governance and sentiment perspective, the filing is neutral; it neither strengthens nor weakens the investment case for VHC.

VirnetX Holding Corp. (VHC) ha presentato un Modulo 4 che riporta una transazione automatica e non discrezionale da parte del Chief Scientist Robert D. Short III il 07/07/2025. La società ha trattenuto 50 azioni ordinarie (Codice Transazione F) al prezzo di $12,34 per adempiere agli obblighi fiscali e previdenziali legati a precedenti premi azionari vincolati. La nota esplicativa conferma che la transazione è esclusivamente per il regolamento fiscale e non comporta una vendita sul mercato aperto.

Dopo la transazione, la proprietà diretta ammonta a 31.848 azioni e quella indiretta a 11.278 azioni detenute tramite The Short Revocable Living Trust, lasciando sostanzialmente invariata l'esposizione economica complessiva di Short. Non sono stati esercitati, acquisiti o ceduti titoli derivati, né sono state divulgate altre attività da parte degli insider. Considerata la dimensione irrilevante (≈0,1% del totale delle partecipazioni di Short) e la natura amministrativa, la comunicazione ha limitata rilevanza per gli investitori e non indica alcun cambiamento nel sentimento degli insider verso VirnetX.

VirnetX Holding Corp. (VHC) presentó un Formulario 4 reportando una transacción automática y no discrecional de un insider, el Chief Scientist Robert D. Short III, el 07/07/2025. La compañía retuvo 50 acciones ordinarias (Código de Transacción F) a un precio de $12.34 para cumplir con obligaciones fiscales y de nómina vinculadas a premios de acciones restringidas otorgadas previamente. La nota explicativa confirma que la transacción es únicamente para el pago de impuestos y no implica una venta en el mercado abierto.

Tras la transacción, la propiedad directa es de 31,848 acciones y la indirecta de 11,278 acciones mantenidas a través de The Short Revocable Living Trust, dejando la exposición económica total de Short prácticamente sin cambios. No se ejercieron, adquirieron ni dispusieron valores derivados, ni se divulgó otra actividad de insiders. Dado el tamaño insignificante (≈0,1 % de las tenencias totales de Short) y su naturaleza administrativa, la presentación tiene poca relevancia para la inversión y no señala un cambio en el sentimiento de los insiders hacia VirnetX.

VirnetX Holding Corp. (VHC)는 2025년 7월 7일 최고 과학자 Robert D. Short III의 자동적이고 비재량적인 내부자 거래를 보고하는 Form 4를 제출했습니다. 회사는 이전에 부여된 제한 주식 보상과 관련된 급여 및 소득세 의무를 충족하기 위해 50주 보통주(거래 코드 F)를 주당 $12.34에 원천징수했습니다. 설명 노트는 이 거래가 엄격히 세금 정산을 위한 것이며 공개 시장 판매와는 관련이 없다고 확인합니다.

거래 후 직접 보유 주식은 31,848주, The Short Revocable Living Trust를 통한 간접 보유 주식은 11,278주로, Short의 전체 경제적 노출은 사실상 변함이 없습니다. 파생 증권의 행사, 취득 또는 처분은 없었으며, 다른 내부자 활동도 공개되지 않았습니다. 거래 규모가 미미(Short 총 보유량의 약 0.1%)하고 행정적 성격임을 고려할 때, 이 제출은 투자에 미치는 영향이 제한적이며 VirnetX에 대한 내부자 심리 변화 신호가 아닙니다.

VirnetX Holding Corp. (VHC) a déposé un formulaire 4 rapportant une transaction interne automatique et non discrétionnaire effectuée par le Chief Scientist Robert D. Short III le 07/07/2025. La société a retenu 50 actions ordinaires (code transaction F) au prix de 12,34 $ pour satisfaire aux obligations fiscales et salariales liées à des attributions d’actions restreintes précédemment accordées. La note explicative confirme que la transaction vise strictement le règlement fiscal et n’implique pas une vente sur le marché libre.

Après la transaction, la détention directe s’élève à 31 848 actions et la détention indirecte à 11 278 actions détenues via The Short Revocable Living Trust, laissant l’exposition économique globale de Short essentiellement inchangée. Aucun titre dérivé n’a été exercé, acquis ou cédé, et aucune autre activité d’initié n’a été divulguée. Étant donné la taille négligeable (≈0,1 % du total des avoirs de Short) et son caractère administratif, ce dépôt a une signification limitée pour les investisseurs et ne signale aucun changement dans le sentiment des initiés envers VirnetX.

VirnetX Holding Corp. (VHC) reichte am 07.07.2025 ein Formular 4 ein, das eine automatische, nicht diskretionäre Insider-Transaktion des Chief Scientist Robert D. Short III meldet. Das Unternehmen behielt 50 Stammaktien (Transaktionscode F) zum Preis von $12,34 ein, um Lohn- und Einkommenssteuerverpflichtungen im Zusammenhang mit zuvor gewährten eingeschränkten Aktien zu erfüllen. Die erläuternde Anmerkung bestätigt, dass die Transaktion ausschließlich der Steuerbegleichung dient und keinen Verkauf am offenen Markt beinhaltet.

Nach der Transaktion hält Short 31.848 direkte Aktien und 11.278 indirekte Aktien, die über The Short Revocable Living Trust gehalten werden, wodurch sich seine wirtschaftliche Gesamtposition im Wesentlichen nicht ändert. Es wurden keine Derivate ausgeübt, erworben oder veräußert, und es wurden keine weiteren Insider-Aktivitäten offengelegt. Aufgrund der unbedeutenden Größe (≈0,1 % von Shorts Gesamtbestand) und des administrativen Charakters hat die Meldung geringe investitionsbezogene Bedeutung und signalisiert keine Veränderung der Insider-Stimmung gegenüber VirnetX.

false 0002028707 0002028707 2025-07-10 2025-07-10 0002028707 BACQ:UnitsEachConsistingOfOneClassOrdinaryShareAndOneRightMember 2025-07-10 2025-07-10 0002028707 BACQ:ClassOrdinarySharesParValue0.0001PerShareMember 2025-07-10 2025-07-10 0002028707 BACQ:RightsEachRightEntitlingHolderToReceiveOnetenth110OfOneClassOrdinaryShareMember 2025-07-10 2025-07-10 iso4217:USD xbrli:shares iso4217:USD xbrli:shares

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 8-K

 

CURRENT REPORT

PURSUANT TO SECTION 13 OR 15(d)

OF THE SECURITIES EXCHANGE ACT OF 1934

 

Date of Report (Date of earliest event reported): July 10, 2025

 

Bleichroeder Acquisition Corp. I

(Exact name of registrant as specified in its charter)

 

Cayman Islands   001-42392   98-1797826

(State or other jurisdiction

of incorporation)

  (Commission File Number)  

(IRS Employer

Identification No.)

 

1345 Avenue of the Americas, Fl 47
New York, NY 10105

(Address of principal executive offices, including zip code)

 

Registrant’s telephone number, including area code: 212-984-3835

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions:

 

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

Securities registered pursuant to Section 12(b) of the Act:

 

Title of each class   Trading Symbol(s)   Name of each exchange on which registered
Units, each consisting of one Class A ordinary share and one right   BACQU   The Nasdaq Stock Market LLC
Class A ordinary shares, par value $0.0001 per share   BACQ   The Nasdaq Stock Market LLC
Rights, each right entitling the holder to receive one-tenth (1/10) of one Class A ordinary share   BACQR   The Nasdaq Stock Market LLC

 

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (§230.405 of this chapter) or Rule 12b-2 of the Securities Exchange Act of 1934 (§240.12b-2 of this chapter).

 

Emerging growth company

 

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act.

 

 

 

 

Item 5.02. Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers; Compensatory Arrangements of Certain Officers.

 

Management Changes

 

Effective July 10, 2025, Andrew Gundlach resigned as President and Chief Executive Officer of Bleichroeder Acquisition Corp. I (the “Company”), and was appointed as Executive Chairman of the Board of Directors (the “Board”).

 

Effective July 10, 2025, Marcello Padula resigned as Chief Financial Officer of the Company.

 

Effective July 10, 2025, Michael Blitzer, Robert Folino and Kevin Shannon were appointed as President and Chief Executive Officer, Chief Financial Officer, and Chief Operating Officer, respectively, of the Company. Mr. Blitzer was also appointed to the Board.

 

Mr. Blitzer and Mr. Shannon are affiliates of Inflection Point Fund I LP, which is a member of Bleichroeder Sponsor 1 LLC, the Company’s sponsor.

  

Michael Blitzer has been the Chairman and CEO of Inflection Point Acquisition Corp. III since October 2024. He served as CEO and director of IPXX from March 2023 to March 2025 and previously served as co-CEO and director of IPAX from February 2021 to February 2023. He currently sits on the board of directors and audit committee of Intuitive Machines, Inc. (Nasdaq: LUNR) and is the chair of the board of directors of USA Rare Earth, Inc. (Nasdaq: USAR). Mr. Blitzer is the founder and co-CEO of Kingstown Capital Management, which he founded in 2006 and grew to a multi-billion asset manager with some of the world’s largest endowments and foundations as clients. Over 19 years, Kingstown has invested in public and private equities, SPACs, PIPEs, and derivatives. At Kingstown, Mr. Blitzer oversaw and participated in nearly all the firm’s investment decisions including countless public and private investments in disruptive growth industries. Mr. Blitzer is also founder and partner of Inflection Point Asset Management, which he co-founded with Kevin Shannon in 2024. Inflection Point Asset Management invests in concentrated SPAC sponsor and PIPE positions, primarily focused on backing the Inflection Point franchise of SPACs. Mr. Blitzer brings an in-depth understanding of public markets and has invested in a variety of corporate transactions such as spin-offs, rights offerings, public offerings, privatizations, and mergers & acquisitions. He was also a public company director of Signature Group Holdings after its exit from bankruptcy in 2011, where he also sat on the audit committee, and was on the board of directors of the European mutual fund TREND AD. Mr. Blitzer began his Wall Street career at J.P. Morgan Securities in 1999 advising companies globally in private debt and equity capital raises followed by work at the investment fund Gotham Asset Management, which was founded by the author and investor Joel Greenblatt. Mr. Blitzer taught courses in Investing at Columbia Business School for five years in the 2010s. He holds an M.B.A. from Columbia Business School and a B.S. from Cornell University where he received the Cornell Tradition Fellowship. Mr. Blitzer is a trustee of Greens Farms Academy in Westport, CT where he is also Treasurer and Chair of the Investment Committee.

 

Robert Folino joined Bleichroeder, a registered investment advisor, as a trader in 2018 where he and Mr. Gundlach worked closely to help establish the firm. In 2019, Mr. Folino was made Chief Operating Officer and Head of Trading of Bleichroeder. He is currently responsible for overseeing all aspects of accounting, tax and financial operations of the funds, the management company, and its general partner entities. Prior to joining Bleichroeder, Mr. Folino worked for First Eagle Investment Management for 22 years, where he held positions of increasing responsibility. He joined Arnhold and S. Bleichroeder, the predecessor firm to First Eagle Investment Management, in 1996 as a junior arbitrage trader for the Merger Arbitrage Department. Mr. Folino holds a BA in Finance from Rider University.

 

Kevin Shannon has been the COO of Inflection Point Acquisition Corp. III since November 2024. He served as Chief of Staff of IPXX from March 2023 until March 2025 and previously served as Chief of Staff of IPAX from March 2021 to February 2023. In his role as Chief of Staff for IPXX and IPAX, Mr. Shannon was an active participant in all target search, negotiation, and due diligence workstreams. Mr. Shannon is a founder and partner of Inflection Point Asset Management, which he co-founded with Michael Blitzer in 2024. Inflection Point Asset Management invests in concentrated SPAC sponsor and PIPE positions, primarily focused on backing the Inflection Point franchise of SPACs. Mr. Shannon also currently serves as Capital Markets Advisor for Intuitive Machines, Inc and as Special Advisor to USA Rare Earth, Inc. Prior to Inflection Point Asset Management, Mr. Shannon was a Principal at The Venture Collective from April of 2023 to March of 2024 helping to source and diligence later stage investments for the venture capital firm. Before that, Mr. Shannon was a Senior Analyst at Kingstown Capital from March of 2021 to March of 2023. Mr. Shannon began his career in Equity Capital Markets at Bank of America, spending time working across the Technology, Industrials, Equity-Linked, and SPAC teams within ECM. Mr. Shannon holds a B.A. from Colgate University.

 

There are no arrangements or understandings between each of Mr. Blitzer, Mr. Folino or Mr. Shannon and any other persons pursuant to which each of them was selected as an officer of the Company. There are also no family relationships between Mr. Blitzer, Mr. Folino or Mr. Shannon and any director or executive officer of the Company, and Mr. Blitzer, Mr. Folino and Mr. Shannon do not have any direct or indirect material interest in any transaction required to be disclosed pursuant to Item 404(a) of Regulation S-K.

  

Board and Committee Changes

 

Effective July 10, 2025, Nazim Cetin and Pierre Weinstein resigned from the Board and the Audit Committee of the Board (the “Audit Committee”). The Company believes that there are no matters requiring disclosure under Item 5.02(a)(iii) of Current Report on Form 8-K.

 

On July 10, 2025, the Board appointed incumbent directors Joseph Samuels and Antoine Theysset to the Audit Committee.

 

1

 

SIGNATURE

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

  BLEICHROEDER ACQUISITION CORP. I
     
Date: July 11, 2025      By: /s/ Michael Blitzer
    Name: Michael Blitzer
    Title: Chief Executive Officer

 

 

2

 

FAQ

What did VirnetX (VHC) disclose in the latest Form 4?

The company reported that Chief Scientist Robert D. Short III had 50 shares withheld on 07/07/2025 to cover tax obligations.

Was the 50-share transaction an open-market sale of VHC stock?

No. The shares were automatically withheld by VirnetX for taxes (Transaction Code F), not sold on the open market.

How many VirnetX shares does Robert D. Short III hold after the transaction?

He owns 31,848 shares directly and 11,278 shares indirectly via The Short Revocable Living Trust.

Did the filing report any derivative securities activity?

No derivative securities were acquired, exercised, or disposed of in this Form 4.

What is the investment significance of this Form 4 for VHC shareholders?

The filing is largely administrative; the small tax-withholding action does not indicate a change in insider sentiment or company outlook.
Bleichroeder Acquisition Corp

NASDAQ:BACQU

BACQU Rankings

BACQU Latest News

BACQU Stock Data

25.43M
Blank Checks
NEW YORK